Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes
Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes |
|
https://doi.org/10.18632/oncotarget.26164
Roberta Coluccia,
Salvatore Raffa,
Danilo Ranieri,
Andrea Micaloni,
Sabatino Valente,
Gerardo Salerno,
Cristina Scrofani,
Marco Testa,
Giovanna Gallo,
Erika Pagannone,
Maria Rosaria Torrisi,
Massimo Volpe,
and Speranza Rubattu
|
| 35028-35040 |
Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O6-methylguanine-DNA methyltransferase with a double arm hybrid molecule
Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O6-methylguanine-DNA methyltransferase with a double arm hybrid molecule |
|
https://doi.org/10.18632/oncotarget.25120
Martin Rupp,
Zhor Senhaji Mouhri,
Christopher Williams,
and Bertrand J. Jean-Claude
|
| 35041-35055 |
Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8
Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 |
|
https://doi.org/10.18632/oncotarget.26147
Chiara Russo,
Chiara Giannotti,
Alessio Signori,
Michele Cea,
Roberto Murialdo,
Alberto Ballestrero,
Stefano Scabini,
Emanuele Romairone,
Patrizio Odetti,
Alessio Nencioni,
and Fiammetta Monacelli
|
| 35056-35068 |
The Cockayne syndrome protein B is involved in the repair of 5-AZA-2′-deoxycytidine-induced DNA lesions
The Cockayne syndrome protein B is involved in the repair of 5-AZA-2′-deoxycytidine-induced DNA lesions |
|
https://doi.org/10.18632/oncotarget.26189
Estefanía Burgos-Morón,
José Manuel Calderón-Montaño,
Nuria Pastor,
Andreas Höglund,
Ángel Ruiz-Castizo,
Inmaculada Domínguez,
Miguel López- Lázaro,
Nabil Hajji,
Thomas Helleday,
Santiago Mateos,
and Manuel Luis Orta
|
| 35069-35084 |
LncRNAs as novel players in hepatocellular carcinoma recurrence
LncRNAs as novel players in hepatocellular carcinoma recurrence |
|
https://doi.org/10.18632/oncotarget.26202
Laura Gramantieri,
Michele Baglioni,
Francesca Fornari,
Maria Antonella Laginestra,
Manuela Ferracin,
Valentina Indio,
Matteo Ravaioli,
Matteo Cescon,
Vanessa De Pace,
Simona Leoni,
Camelia Alexandra Coadă,
Massimo Negrini,
Luigi Bolondi,
and Catia Giovannini
|
| 35085-35099 |
IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment
IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment |
|
https://doi.org/10.18632/oncotarget.26203
Patricia D.B. Tiburcio,
Bing Xiao,
Yi Chai,
Sydney Asper,
Sheryl R. Tripp,
David L. Gillespie,
Randy L. Jensen,
and L. Eric Huang
|
| 35100-35113 |
MicroRNA expression profile during different conditions of hypoxia
MicroRNA expression profile during different conditions of hypoxia |
|
https://doi.org/10.18632/oncotarget.26210
Donato Lacedonia,
Giulia Scioscia,
Grazia Pia Palladino,
Crescenzio Gallo,
Giovanna Elisiana Carpagnano,
Roberto Sabato,
and Maria Pia Foschino Barbaro
|
| 35114-35122 |
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase
CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase |
|
https://doi.org/10.18632/oncotarget.26212
Alessio Montresor,
Lara Toffali,
Antonella Rigo,
Isacco Ferrarini,
Fabrizio Vinante,
and Carlo Laudanna
|
| 35123-35140 |
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines |
|
https://doi.org/10.18632/oncotarget.26216
Nachi Namatame,
Naomi Tamaki,
Yuya Yoshizawa,
Mutsumi Okamura,
Yumiko Nishimura,
Kanami Yamazaki,
Miwa Tanaka,
Takuro Nakamura,
Kentaro Semba,
Takao Yamori,
Shin-ichi Yaguchi,
and Shingo Dan
|
| 35141-35161 |
Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival
Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival |
|
https://doi.org/10.18632/oncotarget.26225
Hanna Engqvist,
Toshima Z. Parris,
Elisabeth Werner Rönnerman,
Elin M.V. Söderberg,
Jana Biermann,
Claudia Mateoiu,
Karin Sundfeldt,
Anikó Kovács,
Per Karlsson,
and Khalil Helou
|
| 35162-35180 |
Brain metastases in ALK-positive NSCLC – time to adjust current treatment algorithms
Brain metastases in ALK-positive NSCLC – time to adjust current treatment algorithms |
|
https://doi.org/10.18632/oncotarget.26073
Frank Griesinger,
Julia Roeper,
Christoph Pöttgen,
Kay C. Willborn,
and Wilfried E.E. Eberhardt
|
| 35181-35194 |
Correction: The nuclear-cytoplasmic trafficking of a chromatin-modifying and remodelling protein (KMT2C), in osteosarcoma
Correction: The nuclear-cytoplasmic trafficking of a chromatin-modifying and remodelling protein (KMT2C), in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.26240
Caterina Chiappetta,
Chiara Puggioni,
Raffaella Carletti,
Vincenzo Petrozza,
Carlo Della Rocca,
and Claudio Di Cristofano
|
| 35195-35195 |
Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5 |
|
https://doi.org/10.18632/oncotarget.26241
Huabo Wang,
Jay Chauhan,
Angela Hu,
Kelsey Pendleton,
Jeremy L. Yap,
Philip E. Sabato,
Jace W. Jones,
Mariarita Perri,
Jianshi Yu,
Erika Cione,
Maureen A. Kane,
Steven Fletcher,
and Edward V. Prochownik
|
| 35196-35196 |
